Rare diseases
Investigational molecules
Locations
Back to Germany262 clinical trials in Bochum, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study
GermanyGermanyStudy on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease
GermanyStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
GermanyStudy of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels
GermanyStudy on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis
GermanyStudy on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis
GermanyStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
GermanyStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
GermanyStudy on Long-Term Safety and Effects of PTC518 for Patients with Huntington's Disease
GermanyStudy on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on skin conditions, including studies for cutaneous lupus erythematosus, hidradenitis suppurativa, and plaque psoriasis. Novel therapeutic approaches are being evaluated to improve treatment outcomes for patients with chronic skin disorders.
Multiple studies are investigating new medications for moderate to severe cases of these conditions.
Innovative research in cancer treatment, particularly focusing on colorectal cancer, pancreatic cancer, gastric cancer, and non-small cell lung cancer. These trials are evaluating targeted therapies and combination treatments.
New therapeutic approaches combining immunotherapy with targeted treatments are being studied.
Studies focusing on heart failure prevention and chronic kidney disease management. Research includes innovative combination therapies and preventive approaches for high-risk patients.
Trials are evaluating new treatment combinations to improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
